Invention Application
- Patent Title: INHIBITION OF MYOSTATIN SIGNAL BY MYOSTATIN SPLICE VARIANT-DERIVED PROTEIN AND UTILIZATION THEREOF
-
Application No.: US17435215Application Date: 2020-02-26
-
Publication No.: US20220135637A1Publication Date: 2022-05-05
- Inventor: Masafumi MATSUO , Kosuke OKAZAKI , Kazuhiro MAETA
- Applicant: KNC LABORATORIES CO., LTD. , Kobe Gakuin Educational Foundation
- Applicant Address: JP Hyogo; JP Hyogo
- Assignee: KNC LABORATORIES CO., LTD.,Kobe Gakuin Educational Foundation
- Current Assignee: KNC LABORATORIES CO., LTD.,Kobe Gakuin Educational Foundation
- Current Assignee Address: JP Hyogo; JP Hyogo
- Priority: JP2019-037915 20190301
- International Application: PCT/JP2020/007671 WO 20200226
- Main IPC: C07K14/495
- IPC: C07K14/495 ; A23L33/18 ; A23K20/147
Abstract:
A method of inhibiting myostatin signaling via a myostatin splice variant-derived protein is provided. The protein and an expression system thereof are applicable to therapy for diseases in which myostatin is involved.
Public/Granted literature
- US12202869B2 Inhibition of myostatin signal by myostatin splice variant-derived protein and utilization thereof Public/Granted day:2025-01-21
Information query
